Transplanting hands to restore function and appearance
Official title: Human Upper Extremity Allotransplantation
Run by Johns Hopkins University · NCT01459107 · Data updated 2026-11-12
This study is testing a new way to do hand transplants for people who have lost their hands to see if it can help them regain function and improve their quality of life.
Quick facts
| Phase | Phase 2 |
|---|---|
| Study type | Interventional |
| Ages | 18 Years to 69 Years |
| Sex | All |
| Enrollment | 30 (estimated) |
| Sponsor | Johns Hopkins University Academic / other |
| Locations | 1 site (Baltimore, Maryland) |
| Status | Recruiting |
| Started | July 21, 2011 |
| Main results expected | June 30, 2036 |
| Study ends | June 30, 2036 |
| Registry record updated | May 12, 2026 |
| Trial ID | NCT01459107 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adults aged 18-69 who have experienced recent or remote upper limb loss and desire hand transplantation.
✕Probably not a fit
Patients with co-existing medical or psycho-social conditions that could complicate the surgical procedure or immunomodulatory protocol may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This Phase II clinical trial focuses on hand transplantation for individuals who have experienced upper limb loss due to trauma, amputation, or congenital defects. The study aims to evaluate a new immunomodulatory protocol that utilizes deceased donor hand transplantation combined with bone marrow cell-based therapy and single-drug immunosuppression. By documenting the outcomes of this approach, the trial seeks to improve the safety and effectiveness of hand transplants, which have been limited by the risks associated with traditional immunosuppressive therapies. Participants will be closely monitored to assess functional recovery and quality of life improvements following the procedure.
Why it matters
Potential benefit: If successful, this study could significantly enhance the quality of life for patients by restoring the functionality and appearance of their hands.
How similar studies have gone: Previous hand transplantation studies have shown promising functional results, but this specific approach with a new immunomodulatory protocol is relatively novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Recipient Inclusion Criteria: * Recent (≥6 months) or remote (i.e., several decades) unilateral or bilateral upper limb loss (below the shoulder) desiring limb transplantation. * Below-shoulder amputation. * Functionless or minimally functional hand desiring removal of functionless / minimally functional hand followed by transplantation. * Male or female and of any race, color or ethnicity. * Aged 18-69 years. * Completes the protocol informed consent form. * No co-existing medical condition which, in the opinion of the study team, could affect the immunomodulatory protocol, surgical procedure, or functional results (see Donor and Recipient Exclusion Criteria below. If the condition is amenable to treatment, the study team must agree that said condition should not significantly enhance the surgical risks of upper extremity transplantation.) * No co-existing psycho-social problems (i.e., alcoholism, drug abuse). * Negative for malignancy for past 5 years. * Negative for HIV at transplant. * Negative crossmatch with donor. * If female of child-bearing potential, negative serum pregnancy test. * If female of child-bearing potential, consent to use reliable contraception for at least one year following transplantation. * Consents to bone marrow infusion as part of the treatment regime. * USA citizen or equivalent, or foreigner with documentation of ability to pay for transplant and required follow-up care. * Patient agrees to comply with the protocol and states a dedication to the immunomodulatory treatment regime. Donor Inclusion Criteria: Donors will be selected by the upper extremity transplant team in conjunction with the organ procurement organization (OPO) according to the following criteria: * Brain dead meeting the criteria for Determination of Death. * Family consent for limb donation. * Stable donor (i.e., does not require excessive vasopressors to maintain blood pressure). * Aged 16 - 65 years. * Limb matched for size with recipient. * Same blood type as recipient. * Negative lymphocytotoxic crossmatch. * Accurately matched for gender, skin tone, and race (relative requirements depending on recipient consent). Exclusion Criteria: • Positive for any of the following conditions: * Untreated sepsis. * HIV (active or seropositive). * Active tuberculosis. * Hepatitis B or C. * Viral encephalitis. * Toxoplasmosis. * Malignancy (within past 5 years). * Current/recent (within 3 months of donation/screening consent) IV drug abuse. * Paralysis of ischemic or traumatic origin. * Inherited peripheral neuropathy. * Infectious, post infectious, or inflammatory (axonal or demyelinating) neuropathy. * Toxic neuropathy (i.e. heavy metal poisoning, drug toxicity, industrial agent exposure). * Mixed connective tissue disease. * Severe deforming rheumatoid or osteoarthritis in the limb. Donor Only: • Tattoos: * Non-professional tattoo within last 6 months, or * Personally identifiable tattoo (i.e., donor name) on potential transplant. Recipient Only: * Type I (insulin-dependent) diabetes mellitus * Conditions that, in the opinion of the study team, may impact the immunomodulatory protocol potentially exposing the recipient to an unacceptable risk under immunosuppressive treatment. * Sensitized recipients with high levels (50%) of panel-reactive human leukocyte antigen (HLA) antibodies. * Conditions that may impact the success of the surgical procedure or increase the risk of postoperative complications including inherited coagulopathies like Hemophilia, Von-Willebrand's disease, Protein C and S deficiency, Thrombocythemias, Thalassemias, Sickle Cell disease, etc. * Mixed connective tissue diseases and collagen diseases can result in poor wound healing after surgery. * Conditions that may impact functional outcomes including Lipopolysaccharidosis and amyloidosis (may impact nerve regeneration) or rare disorders of bone healing like osteopetrosis. * Patients considered unsuitable per the consulted Psychiatrists appraisal.
Where it's running
-
Johns Hopkins University School of Medicine
Baltimore, Maryland, United States Recruiting
Study contacts
- Principal investigator: Damon Cooney, MD, PhD — Johns Hopkins University
- Study coordinator: Jane Littleton, CRNP, MSN
- Email: jlittl38@jhmi.edu
- Phone: 410-955-6875
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Follow-up on upper limb transplant patients
This study looks at how well upper limb transplants are working for patients who had the surgery at least five years ago, focusing on their safety and quality of life.
-
Penile allotransplantation for men with severe penile injuries
This study is testing a new surgery to see if transplanting a penis can help men who have lost theirs due to serious injuries or cancer feel better and improve their quality of life.
-
Conservative Treatment With Relative Motion Flexion Orthosis for Boutonniere Injuries in Fingers
This study tests a Relative Motion Flexion orthosis to treat recent boutonnière injuries of the finger and see if it helps restore finger function without surgery.
-
Predictors of In-Hospital Death in Severe Abdominal Injury
This study will follow adults with severe abdominal trauma at a large Egyptian hospital to see which factors best predict in-hospital death.
-
Resistance and high-impact exercise for bone health in people with below-knee amputation
This study tests a home-based, tele-supervised exercise program to see if resistance and high-impact activities can improve hip bone health in men with unilateral below-knee amputation.
-
Humidification methods in trauma ICU patients on mechanical ventilation
This study tests whether active heated humidifiers or passive heat-and-moisture exchangers work better in trauma ICU patients who need long-term mechanical ventilation.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.